Myomo (MYO) Cash & Current Investments (2016 - 2025)
Myomo (MYO) posted Cash & Current Investments of $19.0 million for Q4 2025, up 46.72% on a QoQ basis from $12.9 million in Q3 2025, and down 24.85% year-over-year from $25.2 million in Q4 2024.
Myomo (MYO) Cash & Current Investments (2016 - 2025) Analysis & Trends
Myomo's Cash & Current Investments history runs 10 years deep, the most recent figure standing at $19.0 million for Q4 2025.
- Quarterly Cash & Current Investments fell 24.85% year-over-year to $19.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.0 million (down 24.85% YoY) and the FY2025 annual result came in at $19.0 million, down 24.85% from the prior year.
- Cash & Current Investments was $19.0 million for Q4 2025 at Myomo, up from $12.9 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $25.2 million in Q4 2024 and bottomed at $5.3 million in Q4 2022.
- A 5-year average of $12.9 million and a median of $11.9 million in 2021 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 65.56% — and 2024, when it surged 184.69%.
- Myomo's Cash & Current Investments stood at $15.5 million in 2021, then slumped by 65.56% to $5.3 million in 2022, then surged by 65.84% to $8.9 million in 2023, then jumped by 184.69% to $25.2 million in 2024, then dropped by 24.85% to $19.0 million in 2025.
- Business Quant data shows MYO's Cash & Current Investments at $19.0 million in Q4 2025, $12.9 million in Q3 2025, and $15.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - | 18.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.97 Mn |
| Sep 30, 2025 | 12.93 Mn |
| Jun 30, 2025 | 15.86 Mn |
| Mar 31, 2025 | 24.47 Mn |
| Dec 31, 2024 | 25.24 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 8.98 Mn |
| Mar 31, 2024 | 10.96 Mn |
| Dec 31, 2023 | 8.87 Mn |
| Sep 30, 2023 | 11.12 Mn |
| Jun 30, 2023 | 8.96 Mn |
| Mar 31, 2023 | 9.26 Mn |
| Dec 31, 2022 | 5.35 Mn |
| Sep 30, 2022 | 7.40 Mn |
| Jun 30, 2022 | 10.24 Mn |
| Mar 31, 2022 | 12.94 Mn |
| Dec 31, 2021 | 15.52 Mn |
| Sep 30, 2021 | 12.61 Mn |
| Jun 30, 2021 | 13.77 Mn |
| Mar 31, 2021 | 17.37 Mn |